Barton P. Bandy
Net Worth

Last updated:

What is Barton P. Bandy net worth?

The estimated net worth of Mr. Barton P. Bandy is at least $5,033,357 as of 5 Aug 2022. He owns shares worth $2,504,838 as insider, has earned $1,020,519 from insider trading and has received compensation worth at least $1,508,000 in ReShape Lifesciences Inc..

What is the salary of Barton P. Bandy?

Mr. Barton P. Bandy salary is $377,000 per year as Pres, Chief Executive Officer & Director in ReShape Lifesciences Inc..

How old is Barton P. Bandy?

Mr. Barton P. Bandy is 62 years old, born in 1963.

What stocks does Barton P. Bandy currently own?

As insider, Mr. Barton P. Bandy owns shares in one company:

Company Title Shares Price per share Total value
ReShape Lifesciences Inc. (RSLS) Pres, Chief Executive Officer & Director 773,098 $3.24 $2,504,838

What does ReShape Lifesciences Inc. do?

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

RSLS logo
RSLS
ReShape Lifesciences Inc.
$3.24

Barton P. Bandy insider trading

ReShape Lifesciences Inc.

Mr. Barton P. Bandy has made 14 insider trades between 2021-2022, according to the Form 4 filled with the SEC. Most recently he sold 11,674 units of RSLS stock worth $5,487 on 5 Aug 2022.

The largest trade he's ever made was exercising 1,186,006 units of RSLS stock on 22 Jul 2021. As of 5 Aug 2022 he still owns at least 773,098 units of RSLS stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock, $0.001 par value per share 11,674 $0.47 $5,487
Sale
Common Stock, $0.001 par value per share 11,442 $0.55 $6,293
Sale
Common Stock, $0.001 par value per share 2,699 $0.96 $2,591
Sale
Common Stock, $0.001 par value per share 8,610 $0.95 $8,180
Sale
Common Stock, $0.001 par value per share 11,417 $0.77 $8,791
Sale
Common Stock, $0.001 par value per share 11,063 $1.13 $12,501
Sale
Common Stock, $0.001 par value per share 6,538 $1.06 $6,930
Sale
Common Stock, $0.001 par value per share 8,324 $1.22 $10,155
Sale
Common Stock, $0.001 par value per share 7,150 $1.79 $12,799
Sale
Common Stock, $0.001 par value per share 13,427 $1.83 $24,571
Sale
Common Stock, $0.001 par value per share 13,505 $2.69 $36,328
Sale
Common Stock, $0.001 par value per share 12,565 $2.77 $34,805
Sale
Common Stock, $0.001 par value per share 294,494 $2.89 $851,088
Sale
Common Stock, $0.001 par value per share 1,186,006 N/A N/A

ReShape Lifesciences key executives

ReShape Lifesciences Inc. executives and other stock owners filed with the SEC: